LiveRamp Launches Agentic AI Partner Program, but Growth Re-Acceleration Remains Unproven

What happened

LiveRamp announced the LiveRamp Agent Builders (LAB) program, aiming to fast-track agentic AI deployments for marketers through partner-built agents. While this positions LiveRamp at the intersection of data collaboration and AI, the program is still in pilot, and its impact on revenue or ARR growth is uncertain. The company's core growth metrics—ARR growth of 7% and subscription net retention of 102%—remain subdued, and the market has reacted cautiously given the lack of near-term financial catalysts. The master report highlights that valuation already prices in 8-10% growth, leaving limited upside without a clear acceleration. This initiative could support the bull case if it drives higher usage and larger deals, but evidence is lacking.

Implication

The agentic program adds to LiveRamp's product narrative but does not alter the near-term risk/reward; the stock still offers better entry near $20, where mid-single-digit growth is priced in. Management must demonstrate that AI agents translate into faster bookings and net retention improvements to justify a higher multiple.

Thesis delta

The LAB program introduces a potential growth vector but does not change the fundamental thesis that LiveRamp needs to re-accelerate ARR growth and net retention to justify current valuation. The program is too early to shift the 'wait' stance; investors should monitor early adoption signs over the next two quarters before adjusting expectations.